Ketotifen in the prophylaxis of childhood asthma

Abstract
A double-blind crossover trial of ketotifen, a mast cell stabilising antihistamine, was performed in a group of 23 young asthmatic children. No useful prophylaxis against bronchoconstriction could be shown.